Identification of Statin’s Action in a Small Cohort of Patients with Major Depression

Simple item page
dc.catalogadorpau
dc.contributor.authorThakkar, Ishani
dc.contributor.authorMassardo, Teresa
dc.contributor.authorPereira, Jaime
dc.contributor.authorQuintana, Juan Carlos
dc.contributor.authorRisco, Luis
dc.contributor.authorSaez, Claudia G.
dc.contributor.authorCorral, Sebastián
dc.contributor.authorVilla, Carolina
dc.contributor.authorSpuler, Jane
dc.contributor.authorOlivares, Nixa
dc.contributor.authorValenzuela, Guillermo
dc.contributor.authorCastro, Gabriel
dc.contributor.authorRiedel, Byron
dc.contributor.authorVicentini, Daniel
dc.contributor.authorMuñoz, Diego
dc.contributor.authorLastra, Raúl
dc.contributor.authorRodriguez-Fernandez, Maria
dc.date.accessioned2024-01-19T19:22:45Z
dc.date.available2024-01-19T19:22:45Z
dc.date.issued2021
dc.description.abstractStatins are widely used as an effective therapy for ischemic vascular disorders and employed for primary and secondary prevention in cardiac and cerebrovascular diseases. Their hemostatic mechanism has also been shown to induce changes in cerebral blood flow that may result in neurocognitive improvement in subjects with Major Depressive Disorder. Behavioral data, various blood tests, and resting-state brain perfusion data were obtained at the start of this study and three months post-therapy from a small cohort of participants diagnosed with Major Depressive Disorder. Subjects received either rosuvastatin (10 mg) or placebo with their standard selective serotonin reuptake inhibitors therapy. At the end of the study, patients using rosuvastatin reported more positive mood changes than placebo users. However, standard statistical tests revealed no significant differences in any non-behavioral variables before and after the study. In contrast, feature selection techniques allowed identifying a small set of variables that may be affected by statin use and contribute to mood improvement. Classification models built to assess the distinguishability between the two groups showed an accuracy higher than 85% using only five selected features: two peripheral platelet activation markers, perfusion abnormality in the left inferior temporal gyrus, Attention Switching Task Reaction latency, and serum phosphorus levels. Thus, using machine learning tools, we could identify factors that may be causing self-reported mood improvement in patients due to statin use, possibly suggesting a regulatory role of statins in the pathogenesis of clinical depression.
dc.fechaingreso.objetodigital2024-05-06
dc.fuente.origenORCID-ene24
dc.identifier.doi10.3390/app11062827
dc.identifier.issn0717-6163
dc.identifier.urihttps://doi.org/10.3390/app11062827
dc.identifier.urihttps://www.mdpi.com/2076-3417/11/6/2827
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/80848
dc.information.autorucEscuela de Medicina; Pereira Quezada, Jaime Andres; 0000-0003-0481-328X; 15456
dc.issue.numero6
dc.language.isoen
dc.nota.accesoContenido completo
dc.revistaApplied Sciences
dc.rightsacceso abierto
dc.subjectDepressiones_ES
dc.subjectFeature selectiones_ES
dc.subjectMachine learninges_ES
dc.subjectRosuvastatines_ES
dc.titleIdentification of Statin’s Action in a Small Cohort of Patients with Major Depressiones_ES
dc.typeartículo
dc.volumen11
sipa.codpersvinculados15456
sipa.trazabilidadORCID;2024-01-08
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
applsci-11-02827.pdf
Size:
1.34 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas